πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

NORTHWEST BIOTHERAPEUTICS Patents

Full USPTO pharma patent portfolio for NORTHWEST BIOTHERAPEUTICS β€” grant dates, expiration, and drug cross-links.

Patents
595
Expiring ≀24m
13

Quick answer

NORTHWEST BIOTHERAPEUTICS has 595 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 13 expire within 24 months β€” use filters for patent-cliff planning.

Page 9 of 13

  1. US 9173840

    Multifunctional self-assembling polymeric nanosystems

    Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9169294

    Anti-angiogenic molecules, nanostructures and uses thereof

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9162968

    Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

    Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9150533

    Local cochlear application of statins for stimulating neurite regrowth in the cochlea

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9149501

    Methods of treating depression and other related diseases

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9139827

    Polyvalent RNA-nanoparticle compositions

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9125942

    Paramagnetic metal-nanodiamond conjugates

    Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9114116

    Neuroprotection by hepatic cells and hepatocyte secretory factors

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9101612

    Secondary structure stabilized NMDA receptor modulators and uses thereof

    Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9095629

    Magnetic nanostructures as theranostic agents

    Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9096689

    Methods and compositions for inhibiting angiogenesis

    Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9090712

    Diagnosis of carcinomas

    Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9090933

    Cancer screening by detection of ultrastructural and molecular markers

    Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9078918

    Inhibition of fibrosis and AF by TGF-beta inhibition in the posterior left atrium (PLA)

    Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9056129

    Precision-guided nanoparticle systems for drug delivery

    Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9055765

    Dietary compositions and related methods of use

    Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9044454

    Regulation of microvasculature occlusion

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9044419

    Vaccine compositions compromising Ξ²s-crystallin for inducing immune responses against components of drusen

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9044392

    Nylon-3 co-polymers and synthetic lung surfactant compositions containing same

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9034829

    pH-sensitive polymer-drug conjugates for targeted delivery of therapeutics

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9028842

    Compositions and methods for treatment, research and therapeutic applications for malaria

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9012594

    Catalyst and byproduct-free native chemical ligation using cyclic thioester precursors

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8999947

    Nucleic acid functionalized nanoparticles for therapeutic applications

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8969340

    Methods for treating chronic pelvic pain syndrome

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8951968

    Methods of treating depression and other related diseases

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8946172

    Method for reducing scarring during wound healing using antisense compounds directed to CTGF

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8940858

    Fibrous microcapsules and methods of assembly and use thereof

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8933071

    Dimethyl fasudil for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8933076

    Pyridazine compounds, compositions and methods

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8927730

    Intramolecular hydrogen-bonded nitric oxide synthase inhibitors

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8895579

    Heterotricyclic AMPA receptor antagonists for treatment of epilepsy, pain, and other neurological disorders and diseases

    Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8889625

    Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia

    Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8889138

    Anti-ADDL antibodies and uses thereof

    Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8883500

    Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy

    Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8841408

    Macromonomers and hydrogel systems using native chemical ligation, and their methods of preparation

    Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8834840

    Magnetic resonance imaging of self-assembled biomaterial scaffolds

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8829025

    Anti-cancer compounds

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8829187

    Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8821922

    Compositions and methods for polymer-caged liposomes

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8796022

    Generation of functional basal forebrain cholinergic neurons from stem cells

    Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8791233

    Maspin-based peptides and methods of use thereof

    Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8791116

    Myosin light chain kinase inhibitor compounds, compositions and related methods of use

    Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8784895

    Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8758796

    Functionalizing implantable devices with a poly (diol citrate) polymer

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8754044

    Neuroprotection by hepatic cells and hepatocyte secretory factors

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8748569

    Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8742141

    Inhibition and treatment of prostate cancer metastasis

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8735075

    Cancer screening by detection of ultrastructural and molecular markers

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does NORTHWEST BIOTHERAPEUTICS have?

595 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do NORTHWEST BIOTHERAPEUTICS patents expire?

13 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.